Ra Capital Management, L.P. Concert Pharmaceuticals, Inc. Transaction History

Ra Capital Management, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$4.27 - $7.2 $9.47 Million - $16 Million	-2,218,907 Reduced 67.09%	1,088,296 $7.29 Million
Q2 2022 Aug 15, 2022	BUY	$2.8 - $6.36 $766,080 - $1.74 Million	273,600 Added 9.02%	3,307,203 $13.9 Million
Q1 2021 May 17, 2021	BUY	$4.86 - $13.07 $5.88 Million - $15.8 Million	1,210,083 Added 66.36%	3,033,603 $15.1 Million
Q4 2020 Feb 16, 2021	SELL	$9.48 - $12.84 $331,363 - $448,809	-34,954 Reduced 1.88%	1,823,520 $23 Million
Q1 2020 May 15, 2020	BUY	$5.98 - $13.09 $11.1 Million - $24.3 Million	1,858,474 New	1,858,474 $16.4 Million

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

Get notified when there are updates to the investment portfolio of Ra Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Ra Capital Management, L.P. with notifications on news.